FHL1 and ovarian cancer: To further investigate the expression of FHL-1 and factor H in vivo we performed immunohistological analysis of tumour tissue samples obtained from 25 patients with serous cystadenocarcinoma, the most common type of malignant ovarian neoplasm (Christopher, 1994).